Progress in the Treatment of Adenomyosis: Research and Application of Integrated Traditional Chinese and Western Medicine

丽婷 葛

doi:10.12677/hjbm.2025.155111

Progress in the Treatment of Adenomyosis: Research and Application of Integrated Traditional Chinese and Western Medicine

丽婷葛

In: Hans Journal of Biomedicine · 2025 · vol. 15(05) , pp. 1038–1043 · doi:10.12677/hjbm.2025.155111 · W4414416192

article OA: closed CC0

Full text JSON View on OpenAlex View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite+body, 2026-07-29 ⓘ

This review summarizes advances in treating adenomyosis with Western medicine, Traditional Chinese medicine, and integrated approaches, evaluating their clinical effects to provide references.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-31 · read from full text ⓘ

This review article examines the current landscape of adenomyosis management by synthesizing evidence from both Western medical and Traditional Chinese Medicine approaches. It categorizes existing treatments into surgical, pharmacological, and interventional methods for Western medicine, while detailing internal herbal remedies, acupuncture, enemas, and acupoint embedding for Traditional Chinese Medicine. The authors summarize the clinical efficacy of these diverse modalities to provide a comprehensive reference for optimizing patient care protocols. This paper is centrally about adenomyosis — specifically reviewing integrated treatment strategies combining traditional Chinese and Western medical practices.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 4,359 characters · extracted from oa-doi-fallback · click to expand

子宫腺肌病的治疗进展：中西医结合的研究与应用 Progress in the Treatment of Adenomyosis: Research and Application of Integrated Traditional Chinese and Western Medicine Progress in the Treatment of Adenomyosis: Research and Application of Integrated Traditional Chinese and Western Medicine DOI: 10.12677/hjbm.2025.155111, PDF, 被引量作者: 葛丽婷, 常新艳*：中国人民解放军联勤保障部队第九二四医院健康医学科，广西桂林关键词: 子宫腺肌病；手术治疗；药物治疗；中医内治法；中医外治法；Adenomyosis； Surgical Treatment； Medication； Traditional Chinese Medicine Internal Treatment Method； Traditional Chinese Medicine External Treatment Methods 作者: 葛丽婷, 常新艳*：中国人民解放军联勤保障部队第九二四医院健康医学科，广西桂林关键词: 子宫腺肌病；手术治疗；药物治疗；中医内治法；中医外治法；Adenomyosis； Surgical Treatment； Medication； Traditional Chinese Medicine Internal Treatment Method； Traditional Chinese Medicine External Treatment Methods 摘要: 子宫腺肌病由于子宫内膜侵入肌层而引起周期性出血，在一定程度上影响患者的生活质量。目前，临床西医对子宫腺肌病的治疗主要有手术、药物、介入等手段；中医治疗主要为中药内服、针灸、灌肠、穴位埋线等。为此，对子宫腺肌病的中西医治疗进展进行了综述，对这类患者不同治疗方法的效果进行了总结，旨在为临床提供更多的借鉴。 Abstract: Adenomyosis causes periodic bleeding due to the invasion of the endometrium into the muscular layer, which to some extent affects the quality of life of patients. At present, clinical Western medicine mainly uses surgical, pharmacological, and interventional methods to treat adenomyosis; Traditional Chinese medicine treatment mainly includes oral administration of traditional Chinese medicine, acupuncture and moxibustion, enema, acupoint catgut embedding, etc. For this purpose, a review was conducted on the progress of traditional Chinese and Western medicine treatment for adenomyosis, summarizing the effects of different treatment methods for such patients, with the aim of providing more references for clinical practice. 文章引用：葛丽婷, 常新艳. 子宫腺肌病的治疗进展：中西医结合的研究与应用[J]. 生物医学, 2025, 15(5): 1038-1043. https://doi.org/10.12677/hjbm.2025.155111 | [1] | Sun, C., Ren, X.Y., Liang, Z.G., Mou, M., et al. (2020) Clinical Efficacy and Safety of Major Uterine Wall Resection and Reconstruction of the Uterus Combined with LNG-IUS for the Treatment of Severe Adenomyosis. Geburtshilfe und Frauenheilkunde, 80, 300-306. [Google Scholar] [CrossRef] [PubMed] | | [2] | 张开心, 邓婷婷, 董志斌, 等. 温针灸联合隔药灸脐治疗子宫腺肌病的疗效观察[J]. 上海针灸杂志, 2022, 41(6): 585-588. | | [3] | 孟凡婷, 田颖, 赵霞, 等. 术前使用促性腺激素释放激素激动剂治疗子宫腺肌病病灶广泛切除的效果评价[J]. 中国临床医生杂志, 2020, 48(10): 1243-1246. | | [4] | 桂甜甜, 张小倩, 赵秉莳, 等. 宫腔镜电切联合孕激素治疗子宫腺肌病的效果研究[J]. 宁夏医科大学学报, 2022, 44(3): 307-312. | | [5] | 赵守辉, 闫国珍, 刘扬, 等. 微波消融联合GnRH-a与LNG-IUS治疗弥漫性子宫腺肌病临床研究[J]. 中国超声医学杂志, 2022, 38(2): 189-192. | | [6] | 王默琳, 郭红燕, 高欣然, 刘露, 韩肖彤. 地诺孕素用于治疗不同MRI分型子宫腺肌病的疗效评价[J]. 中华妇产科杂志, 2025, 60(7): 511-519. | | [7] | 王宝俊, 周琦, 邹运. 左炔诺孕酮宫内缓释系统联合宫腔形宫内节育器治疗子宫腺肌病临床效果观察[J]. 临床军医杂志, 2022, 50(5): 510-513. | | [8] | 吴楚婷, 李欣荣, 董晓燕, 等. 温针疗法治疗寒凝血瘀型子宫腺肌病的疗效观察[J]. 上海针灸杂志, 2022, 41(7): 691-696. | | [9] | 师伟, 陈思儒, 刘志勇. 中医综合方案治疗子宫腺肌病临床诊疗流程优化研究[J]. 山东中医杂志, 2021, 40(3): 221-226. | | [10] | 杨爽灵, 郑兰兰, 李志岗. 子宫腺肌病超声消融治疗有效性及影响疗效的危险因素分析[J]. 深圳中西医结合杂志, 2025, 35(4): 23-27. | | [11] | Alborzi, S., Askary, E., Khorami, F., et al. (2021) A Detailed Study in Adenomyosis and Endometriosis: Evaluation of the Rate of Coexistence between Uterine Adenomyosis and DIE According to Imaging and Histopathology Findings. Reproductive Sciences, 28, 2387-2397. [Google Scholar] [CrossRef] [PubMed] | | [12] | 程晓嫚, 田丽颖, 王芬, 等. 膈下逐瘀汤加减联合针刺治疗气滞血瘀证盆腔炎后遗症的疗效及对炎症指标、血液流变学的影响[J]. 中国医院用药评价与分析, 2023, 23(9): 1056-1059. | | [13] | 刘会玲, 徐泽霞, 李颖. 祛湿化瘀散结汤联合桂枝茯苓胶囊治疗痰湿瘀结证子宫肌瘤临床研究[J]. 新中医, 2023, 55(23): 130-135. | | [14] | 吴芳, 杨冬梅, 李鹏利. 清热调血汤联合穴位埋线对湿热瘀结型痛经患者镇痛效应、子宫动脉血流动力学及前列腺素E2、前列腺素F2α、β内啡肽的影响[J]. 环球中医药, 2021, 14(3): 525-527. | | [15] | 尹宁, 王彩虹, 荆改丽, 等. 补肾祛瘀方对肾虚血瘀型子宫内膜异位症痛经相关因子的影响研究[J]. 中华中医药学刊, 2021, 39(2): 66-68. | | [16] | 程文秀, 丁楠, 陈思儒, 等. 基于瘀毒理论治疗子宫腺肌病浅析[J]. 西部中医药, 2022, 35(3): 127-129. | | [17] | 应翩, 杨华娣, 张颖, 等. 裘氏内异方联合GnRH-a治疗腹腔镜下子宫腺肌病病灶切除术后的临床观察[J]. 中国中西医结合杂志, 2020, 40(4): 401-405. | | [18] | 陈燕, 石家振, 赵霞. 行气化瘀消癥汤联合孕三烯酮治疗子宫腺肌病的临床观察[J]. 中国中医药科技, 2021, 28(5): 830-831. | | [19] | 张茜, 林彬, 马娟娟, 等. 清热化瘀中药对子宫腺肌病患者高强度聚焦超声术后炎症的影响[J]. 上海中医药杂志, 2021, 55(5): 58-62. | | [20] | 吴霏霏, 杨君, 许鑫. 地诺孕素与促性腺激素释放激素激动剂联合替勃龙反向添加在子宫腺肌病保守手术后的应用效果比较[J]. 新乡医学院学报, 2023, 40(9): 834-839. | | [21] | 王娟, 周守国, 黄耀渠. 磁共振引导聚焦超声术治疗难治性子宫腺肌病的疗效评估[J]. 放射学实践, 2022, 37(5): 584-588. | | [22] | 陈彩霞, 赵海云, 毛福兰, 等. 自拟温阳活血汤联合孕三烯酮胶囊治疗子宫腺肌病痛经临床研究[J]. 国际中医中药杂志, 2020, 42(9): 861-865. | | [23] | 应翩, 王佳曦, 杨华娣, 等. 复方大血藤灌肠剂联合地屈孕酮治疗子宫腺肌病腹腔镜术后的临床疗效研究[J]. 中国全科医学, 2022, 25(18): 2286-2290. |

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (4)

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall: last seen: 2026-09-13T06:26:10.529621+00:00

License: CC0 · commercial use OK

[1] A Detailed Study in Adenomyosis and Endometriosis: Evaluation of the Rate of Coexistence Between Uterine Adenomyosis and DIE According to Imaging and Histopathology Findings 2021

[2] Clinical Efficacy and Safety of Major Uterine Wall Resection and Reconstruction of the Uterus Combined with LNG-IUS for the Treatment of Severe Adenomyosis 2019